Gynecology & Obstetrics (all articles) | Page 41 of 86 | Links Medicus Content Curation & Alerts in Medicine

Nurse Home Visiting and Maternal Mental Health: 3-Year Follow-Up of a Randomized Trial

26 Jan, 2021 | 00:42h | UTC

Nurse Home Visiting and Maternal Mental Health: 3-Year Follow-Up of a Randomized Trial – Pediatrics (link to abstract – $ for full-text)

Global variation in postoperative mortality and complications after cancer surgery: a multicenter, prospective cohort study in 82 countries

25 Jan, 2021 | 01:21h | UTC

Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries – The Lancet

Commentary: Better post-surgical care would boost cancer survival chances – University of Birmingham

Commentary on Twitter (thread – Click for more)

@GlobalSurg 3: Global variation in postoperative mortality & complications after cancer surgery, published in @TheLancet
16K patients underwent surgery across 82 countries.
Better postoperative care & facilities could significantly improve #cancer survivalhttps://t.co/QBRwGgyhLu pic.twitter.com/8f9T1N4O9i

— Ewen Harrison (@ewenharrison) January 21, 2021

Audio interview: An international look at Covid-19

22 Jan, 2021 | 08:33h | UTC

Audio Interview: An International Look at Covid-19 – New England Journal of Medicine

Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews

21 Jan, 2021 | 00:59h | UTC

Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews – Cochrane Library

Commentary: What are the most effective interventions during pregnancy for preventing stillbirth? – Cochrane Library

Commentary on Twitter

@CochranePCG overview of Cochrane systematic reviews included 43 Cochrane reviews that assessed 61 different ways of preventing stillbirth during pregnancy, or infant deaths around the time of birth. Read the feature https://t.co/ijf9Id8jjO & full review https://t.co/tMZsCVhs3m

— Cochrane Neonatal (@CochraneNeonate) January 7, 2021

Perspective: Covid-19 vaccine guidance for those who are lactating is based on faulty assumptions, experts say

20 Jan, 2021 | 01:40h | UTC

Covid-19 vaccine guidance for those who are lactating is based on faulty assumptions, experts say – STAT

Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19

19 Jan, 2021 | 01:45h | UTC

Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19 – JAMA Internal Medicine

Commentary: Covid-19 Risks To Pregnant Patients. New Data Shows Risk Of Serious Complications Are Increased But Remain Rare – Brief19

Commentary on Twitter

The higher rates of preterm birth, preeclampsia, thrombotic events and death in women giving birth with #COVID19 highlight the need for strategies to minimize risk https://t.co/W8PtvAKkgt

— JAMA Internal Medicine (@JAMAInternalMed) January 15, 2021

Postdischarge virtual visits for low-risk surgeries: A randomized noninferiority clinical trial

17 Jan, 2021 | 21:57h | UTC

Postdischarge Virtual Visits for Low-risk Surgeries: A Randomized Noninferiority Clinical Trial – JAMA Surgery (free for a limited period)

Commentary: Surgical Centers Warm Up to Video Chats, Texts for Patient Follow-Up – MedPage Today (free registration required)

Study: Seizure frequency does not increase during Pregnancy

15 Jan, 2021 | 08:28h | UTC

Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: MONEAD Study: Does Pregnancy Lead to Increased Seizure Frequency in Women with Epilepsy? – Physician’s Weekly AND Pregnancy Does Not Increase Seizures in Women With Epilepsy – Medscape

Randomized trial: Prophylactic negative pressure wound therapy after laparotomy for gynecologic surgery did not lower the wound complication rate but did increase skin blistering

14 Jan, 2021 | 01:39h | UTC

Prophylactic Negative Pressure Wound Therapy After Laparotomy for Gynecologic Surgery: A Randomized Controlled Trial – Obstetrics & Gynecology

Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response

13 Jan, 2021 | 02:10h | UTC

Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response – Vaccine

Commentaries on Twitter

New paper via our PREVENT Group w 22 concrete recs that provide a roadmap for the ethically responsible, socially just, & respectful inclusion of the interests of pregnant women in the development & deployment of vaccines against emerging pathogens. https://t.co/tp6gt20dh0

— Ruth Faden (@fadenethx) May 6, 2019

Infectious disease outbreaks can severely affect the health interests of pregnant women and their babies. PREVENT's guidance promotes the inclusion of pregnant women in the development and deployment of vaccines against emerging pathogens ➡️ https://t.co/P8IKXCU8tI pic.twitter.com/LYDHfQ2f9y

— CEPI (@CEPIvaccines) May 13, 2019

Covid-19: Breastfeeding women can have vaccine after guidance turnaround

13 Jan, 2021 | 02:11h | UTC

Covid-19: Breastfeeding women can have vaccine after guidance turnaround – The BMJ

Systematic review: Treatment with antenatal corticosteroids in women at risk of preterm birth reduces the risk of perinatal death, neonatal death, respiratory distress syndrome, and the risk of intraventricular hemorrhage

13 Jan, 2021 | 01:46h | UTC

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth – Cochrane Library

Summary: What are the benefits and risks of giving corticosteroids to pregnant women at risk of premature birth? – Cochrane Library

Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action

18 Dec, 2020 | 09:52h | UTC

Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action – The Lancet Global Health

Commentaries: Pregnant women excluded from three-quarters of COVID-19 treatment trials – The Lancet AND Expert reaction to opinion piece on pregnant women and COVID-19 treatment trials – Science Media Centre

Commentary on Twitter (thread – click for more)

NEW—Pregnant women are among those most in need of safe and effective therapies against #COVID19, but are routinely excluded from 3/4 of treatment trials. Read the review published in @LancetGH: https://t.co/xvBfHqnHMe @WHO pic.twitter.com/pBuTcsUZ0O

— The Lancet (@TheLancet) December 17, 2020

CDC Guidelines for Gonococcal Infection, 2020. CDC recommends a single 500 mg intramuscular dose of ceftriaxone for uncomplicated gonorrhea, with oral doxycycline for 7 days when chlamydial coinfection has not been excluded

18 Dec, 2020 | 09:40h | UTC

Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020 – Centers for Disease Control and Prevention

Commentary: CDC Guidelines Recommend Ceftriaxone Monotherapy for Uncomplicated Gonorrhea – NEJM Journal Watch

Commentary on Twitter

New recommendations by the CDC for gonococcal infections pic.twitter.com/ZYbMt5cpyP

— Garrett Hile, PharmD, BCCCP (@GarrettHile) December 18, 2020

AHA Scientific Statement: Menopause transition and cardiovascular disease risk

15 Dec, 2020 | 01:32h | UTC

Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association – Circulation

News release: Heart disease risk in women increases leading up to menopause; early intervention is key – American Heart Association

Top Things to Know: Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention

Commentaries: Menopause Transition and Cardiovascular Health: Time Matters – American Heart Association AND Report on latest menopause science looks at heart risks – American Heart Association AND Menopause Transition and CVD Risk: AHA Scientific Statement – American College of Cardiology

Randomized trial: Among women with urinary incontinence, biofeedback-mediated intensive pelvic floor training does not provide additional benefit to basic pelvic floor muscle training

15 Dec, 2020 | 01:23h | UTC

Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCT – Health Technology Assessment

Meta-analysis: Induction of labor at 41 weeks improves perinatal outcomes compared with expectant management until 42 weeks, without increasing the cesarean delivery rate

15 Dec, 2020 | 01:21h | UTC

Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials – PLOS Medicine

Commentary: More support for induction at 41 weeks’ pregnancy, especially for first time mothers – University of Gothenburg

The USPSTF draft statement recommends behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy

13 Dec, 2020 | 23:18h | UTC

Healthy Weight and Weight Gain During Pregnancy: Behavioral Counseling Interventions – U.S. Preventive Services Task Force

Commentary: USPSTF in favor of interventions for healthy weight gain in pregnancy

Vast majority of pregnant women with COVID-19 won’t have complications, study finds

10 Dec, 2020 | 08:39h | UTC

Vast Majority of Pregnant Women with COVID-19 Won’t Have Complications, Study Finds – NIH Director’s Blog

Original study: Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection – JAMA Network Open

Randomized trial: In pregnant women with mild and moderate chronic hypertension, the use of labetalol was associated with more adverse events compared to methyldopa or no medication

8 Dec, 2020 | 07:26h | UTC

Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial – Hypertension in Pregnancy

Commentary: Methyldopa versus labetalol or no medication for the treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial – Physician’s Weekly

Meta-analysis: Oxytocin used as first‐line treatment of postpartum hemorrhage probably is more effective than misoprostol with less side‐effects. The evidence for most other uterotonic agents is limited.

3 Dec, 2020 | 08:31h | UTC

Uterotonic agents for first‐line treatment of postpartum haemorrhage: a network meta‐analysis – Cochrane Library

Summary: Which drug is best for treating excessive bleeding after childbirth? – Cochrane Library

Review: Perioperative venous thromboembolism prophylaxis

3 Dec, 2020 | 08:28h | UTC

Perioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings

Randomized trial: Intravenous iron is superior to oral iron for the treatment of anemia in women after childbirth in a low-income setting

27 Nov, 2020 | 08:41h | UTC

Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial – The Lancet Global Health

Commentary: Iron infusion highly effective to treat anemia in low-income settings – Swiss Tropical and Public Health Institute / News Medical

Commentary on Twitter

In a randomised trial in Tanzania, intravenous ferric carboxymaltose proved safe and better than oral iron at achieving haemoglobin normalisation (>115 g/L) at 6 weeks after childbirth in women with iron deficiency anaemia https://t.co/F5sau45dwL pic.twitter.com/qqa8cGbMqZ

— The Lancet Global Health (@LancetGH) November 25, 2020